Metabolic Syndrome Blunts Aspirin's Antiplatelet Activity

NEW ORLEANS — Apparently healthy people with a family history of coronary artery disease who also had metabolic syndrome showed elevated platelet aggregation and reduced platelet responsiveness to aspirin in a study of more than 2,000 people.